Post-stroke depression: A review

American Journal of Psychiatry

Volumn 173, Issue 3, 2016, Pages 221-231

  Robinson, Robert G ^a   Jorge, Ricardo E ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; GLUTAMIC ACID; METHYLPHENIDATE; NORTRIPTYLINE; PLACEBO; REBOXETINE; TRAZODONE;

CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DEPRESSION; DRUG EFFICACY; EARLY INTERVENTION; EPIGENETICS; GENETIC ASSOCIATION; HUMAN; MAJOR DEPRESSION; MOOD DISORDER; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; POST STROKE DEPRESSION; PRIORITY JOURNAL; PSYCHIATRIST; REVIEW; STROKE PATIENT; SURVIVAL TIME; WHITE MATTER LESION; CEREBROVASCULAR ACCIDENT; COGNITION; COMPLICATION; DEPRESSIVE DISORDER; PHYSIOLOGY; PROGNOSIS; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR;

ANTIDEPRESSIVE AGENTS; COGNITION; DEPRESSIVE DISORDER; HUMANS; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; STROKE;

EID: 84959530410     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2015.15030363     Document Type: Review

References (91)

1. Mozaffarian D, Benjamin EJ, Go AS, et al: Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 2015;131:e29-e322
2. Roth M: The natural history of mental disorder in old age. J Ment Sci 1955;101:281-301
3. Folstein MF, Maiberger R, McHugh PR: Mood disorder as a specific complication of stroke. J Neurol Neurosurg Psychiatry 1977;40:1018-1020
4. Robinson RG, Starr LB, Kubos KL, et al: A two-year longitudinal study of post-stroke mood disorders: findings during the initial evaluation. Stroke 1983;14:736-741
5. Robinson RG, Kubos KL, Starr LB, et al: Mood disorders in stroke patients: importance of location of lesion. Brain 1984;107:81-93
6. Lipsey JR, Robinson RG, Pearlson GD, et al: Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet 1984;1:297-300
7. Alexopoulos GS, Meyers BS, Young RC, et al: "Vascular depression" hypothesis. Arch Gen Psychiatry 1997;54:915-922
8. Krishnan KR, Hays JC, Blazer DG: MRI-defined vascular depression. Am J Psychiatry 1997;154:497-501
9. Taylor WD, Steffens DC, MacFall JR, et al: White matter hyperintensity progression and late-life depression outcomes. Arch Gen Psychiatry 2003;60:1090-1096
10. Lipsey JR, Spencer WC, Rabins PV, et al: Phenomenological comparison of poststroke depression and functional depression. Am J Psychiatry 1986;143:527-529
11. Mast BT, Yochim B, MacNeill SE, et al: Risk factors for geriatric depression: the importance of executive functioning within the vascular depression hypothesis. J Gerontol A Biol Sci Med Sci 2004;59:1290-1294
12. Robinson RG, Starr LB, Lipsey JR, et al: A two-year longitudinal study of post-stroke mood disorders: dynamic changes in associated variables over the first six months of follow-up. Stroke 1984;15:510-517
13. Mast BT, MacNeill SE, Lichtenberg PA: Post-stroke and clinicallydefined vascular depression in geriatric rehabilitation patients. Am J Geriatr Psychiatry 2004;12:84-92
14. Ayerbe L, Ayis S, Wolfe CD, et al: Natural history, predictors and outcomes of depression after stroke: systematic review and metaanalysis. Br J Psychiatry 2013;202:14-21
15. Hackett ML, Pickles K: Part I: frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies. Int J Stroke 2014;9:1017-1025
16. House A, Dennis M, Mogridge L, et al: Mood disorders in the year after first stroke. Br J Psychiatry 1991;158:83-92
17. Spalletta G, Robinson RG: How should depression be diagnosed in patients with stroke? Acta Psychiatr Scand 2010;121:401-403
18. Robinson RG: The Clinical Neuropsychiatry of Stroke, 2nd ed. New York, Cambridge University Press, 2006, p 470
19. Kohen R, Cain KC, Mitchell PH, et al: Association of serotonin transporter gene polymorphisms with poststroke depression. Arch Gen Psychiatry 2008;65:1296-1302
20. Kim JM, Stewart R, Kang HJ, et al: A longitudinal study of SLC6A4 DNA promoter methylation and poststroke depression. J Psychiatr Res 2013;47:1222-1227
21. Kim JM, Stewart R, Kang HJ, et al: A longitudinal study of BDNF promoter methylation and genotype with poststroke depression. J Affect Disord 2013;149:93-99
22. De Ryck A, Brouns R, Geurden M, et al: Risk factors for poststroke depression: identification of inconsistencies based on a systematic review. J Geriatr Psychiatry Neurol 2014;27:147-158
23. Kutlubaev MA, Hackett ML: Part II: predictors of depression after stroke and impact of depression on stroke outcome: an updated systematic review of observational studies. Int J Stroke 2014;9:1026-1036
24. Johnson JL, Minarik PA, Nyström KV, et al: Poststroke depression incidence and risk factors: an integrative literature review. J Neurosci Nurs 2006;38(suppl):316-327
25. Tenev VT, Robinson RG, Jorge RE: Is family history of depression a risk factor for poststroke depression? meta-analysis. Am J Geriatr Psychiatry 2009;17:276-280
26. Starkstein SE, Robinson RG, Price TR: Comparison of cortical and subcortical lesions in the production of poststroke mood disorders. Brain 1987;110:1045-1059
27. Narushima K, Kosier JT, Robinson RG: A reappraisal of poststroke depression, intra- and inter-hemispheric lesion location using metaanalysis. J Neuropsychiatry Clin Neurosci 2003;15:422-430
28. Wei N, Yong W, Li X, et al: Post-stroke depression and lesion location: a systematic review. J Neurol 2015;262:81-90
29. Rajashekaran P, Pai K, Thunga R, et al: Post-stroke depression and lesion location: a hospital based cross-sectional study. Indian J Psychiatry 2013;55:343-348
30. Davidson RJ, Irwin W: The functional neuroanatomy of emotion and affective style. Trends Cogn Sci 1999;3:11-21
31. Jorge RE, Moser DJ, Acion L, et al: Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry 2008;65:268-276
32. Hackett ML, Köhler S, O'Brien JT, et al: Neuropsychiatric outcomes of stroke. Lancet Neurol 2014;13:525-534
33. Starkstein SE, Robinson RG, Price TR: Comparison of patients with and without poststroke major depression matched for size and location of lesion. Arch Gen Psychiatry 1988;45:247-252
34. Bolla-Wilson K, Robinson RG, Starkstein SE, et al: Lateralization of dementia of depression in stroke patients. Am J Psychiatry 1989;146:627-634
35. Herrmann N, Black SE, Lawrence J, et al: The Sunnybrook Stroke Study: a prospective study of depressive symptoms and functional outcome. Stroke 1998;29:618-624
36. Parikh RM, Robinson RG, Lipsey JR, et al: The impact of poststroke depression on recovery in activities of daily living over a 2-year follow-up. Arch Neurol 1990;47:785-789
37. Bilge C, Koçer E, Koçer A, et al: Depression and functional outcome after stroke: the effect of antidepressant therapy on functional recovery. Eur J Phys Rehabil Med 2008;44:13-18
38. Paolucci S, Grasso MG, Antonucci G, et al: One-year follow-up in stroke patients discharged from rehabilitation hospital. Cerebrovasc Dis 2000;10:25-32
39. Chemerinski E, Robinson RG, Arndt S, et al: The effect of remission of poststroke depression on activities of daily living in a double-blind randomized treatment study. J Nerv Ment Dis 2001;189:421-425
40. Kimura M, Robinson RG, Kosier JT: Treatment of cognitive impairment after poststroke depression: a double-blind treatment trial. Stroke 2000;31:1482-1486
41. Morris PL, Robinson RG, Andrzejewski P, et al: Association of depression with 10-year poststroke mortality. Am J Psychiatry 1993;150:124-129
42. House A, Knapp P, Bamford J, et al: Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month. Stroke 2001;32:696-701
43. Williams LS, Ghose SS, Swindle RW: Depression and other mental health diagnoses increase mortality risk after ischemic stroke. Am J Psychiatry 2004;161:1090-1095
44. Ayerbe L, Ayis S, Crichton SL, et al: Explanatory factors for the increased mortality of stroke patients with depression. Neurology 2014;83:2007-2012
45. Ayerbe L, Ayis S, Crichton S, et al: The long-term outcomes of depression up to 10 years after stroke; the South London Stroke Register. J Neurol Neurosurg Psychiatry 2014;85:514-521
46. Carney RM, Blumenthal JA, Freedland KE, et al: Low heart rate variabilityand the effect of depression on post-myocardial infarction mortality. Arch Intern Med 2005;165:1486-1491
47. Robinson RG, Spalletta G, Jorge RE, et al: Decreased heart rate variability is associated with poststroke depression. Am J Geriatr Psychiatry 2008;16:867-873
48. Jorge RE, Robinson RG, Arndt S, et al: Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry 2003;160:1823-1829
49. Ried LD, Jia H, Feng H, et al: Selective serotonin reuptake inhibitor treatment and depression are associated with poststroke mortality. Ann Pharmacother 2011;45:888-897
50. Chollet F, Tardy J, Albucher JF, et al: Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebocontrolled trial. Lancet Neurol 2011;10:123-130
51. Jorge RE, Acion L, Moser D, et al: Escitalopramand enhancement of cognitive recovery following stroke. Arch Gen Psychiatry 2010;67:187-196
52. Mikami K, Jorge RE, Adams HP Jr, et al: Effect of antidepressants on the course of disability following stroke. Am J Geriatr Psychiatry 2011;19:1007-1015
53. Mead GE, Hsieh CF, Hackett M: Selective serotonin reuptake inhibitors for stroke recovery. JAMA 2013;310:1066-1067
54. Kraglund KL, Mortensen JK, Grove EL, et al: TALOS: a multicenter, randomized, double-blind, placebo-controlled trial to test the effects of citalopram in patients with acute stroke. Int J Stroke 2015;10:985-987
55. De Ryck A, Fransen E, Brouns R, et al: Poststroke depression and its multifactorial nature: results from a prospective longitudinal study. J Neurol Sci 2014;347:159-166
56. Li W, Ling S, Yang Y, et al: Systematic hypothesis for post-stroke depressioncaused inflammation and neurotransmission and resultant on possible treatments. Neuroendocrinol Lett 2014;35:104-109
57. Aström M, Olsson T, Asplund K: Different linkage of depression to hypercortisolism early versus late after stroke: a 3-year longitudinal study. Stroke 1993;24:52-57
58. Taylor WD, Aizenstein HJ, Alexopoulos GS: Thevascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry 2013;18:963-974
59. Noonan K, Carey LM, Crewther SG: Meta-analyses indicate associations between neuroendocrine activation, deactivation in neurotrophic and neuroimaging markers in depression after stroke. J Stroke Cerebrovasc Dis 2013;22:e124-e135
60. Spalletta G, Bossù P, Ciaramella A, et al: The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry 2006;11:984-991
61. Robinson RG, Shoemaker WJ, Schlumpf M, et al: Effect of experimental cerebral infarction in rat brain on catecholamines and behaviour. Nature 1975;255:332-334
62. Robinson RG: Differential behavioral and biochemical effects of rightand left hemispheric cerebral infarction in the rat. Science 1979;205:707-710
63. Kronenberg G, Balkaya M, Prinz V, et al: Exofocal dopaminergic degeneration as antidepressant target in mouse model of poststroke depression. Biol Psychiatry 2012;72:273-281
64. Wang SH, Zhang ZJ, Guo YJ, et al: Involvement of serotonin neurotransmission in hippocampal neurogenesis and behavioral responses in a rat model of post-stroke depression. Pharmacol Biochem Behav 2010;95:129-137
65. Bryer JB, Starkstein SE, Votypka V, et al: Reduction of CSF monoamine metabolites in poststroke depression: a preliminary report. J Neuropsychiatry Clin Neurosci 1992;4:440-442
66. Lassalle-Lagadec S, Sibon I, Dilharreguy B, et al: Subacute default mode network dysfunction in the prediction of post-stroke depression severity. Radiology 2012;264:218-224
67. Spalletta G, Cravello L, Imperiale F, et al: Neuropsychiatric symptoms and interleukin-6 serum levels in acute stroke. J Neuropsychiatry Clin Neurosci 2013;25:255-263
68. Fang J, Cheng Q: Etiological mechanisms of post-stroke depression: a review. Neurol Res 2009;31:904-909
69. Li J, Zhao YD, Zeng JW, et al: Serum brain-derived neurotrophic factor levels in post-stroke depression. J Affect Disord 2014;168:373-379
70. Koo JW, Russo SJ, Ferguson D, et al: Nuclear factor-kappa B is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci USA 2010;107:2669-2674
71. Glodzik-Sobanska L, Slowik A, McHugh P, et al: Single voxel proton magnetic resonance spectroscopy in post-stroke depression. Psychiatry Res 2006;148:111-120
72. Andersen G, Vestergaard K, Lauritzen L: Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994;25:1099-1104
73. Hackett ML, Anderson CS, House A, et al: Interventions for treating depression after stroke. Cochrane Database Syst Rev 2008; (4): CD003437
74. Mitchell PH, Veith RC, Becker KJ, et al: Brief psychosocial-behavioral intervention with antidepressant reduces poststroke depression significantly more than usual care with antidepressant: living well with stroke: randomized, controlled trial. Stroke 2009;40:3073-3078
75. Williams LS, Kroenke K, Bakas T, et al: Care management of poststroke depression: a randomized, controlled trial. Stroke 2007;38:998-1003
76. Coupland C, Dhiman P, Morriss R, et al: Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 2011;343:d4551
77. Smoller JW, Allison M, Cochrane BB, et al: Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative Study. Arch Intern Med 2009;169:2128-2139
78. Hackam DG, Mrkobrada M: Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis. Neurology 2012;79:1862-1865
79. Robinson RG, Jorge RE, Moser DJ, et al: Escitalopram and problemsolving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 2008;299:2391-2400
80. Salter KL, Foley NC, Zhu L, et al: Prevention of poststroke depression: Does prophylactic pharmacotherapy work? J Stroke Cerebrovasc Dis 2013;22:1243-1251
81. Mikami K, Jorge RE, Moser DJ, et al: Prevention of post-stroke generalized anxiety disorder, using escitalopram or problem-solving therapy. J Neuropsychiatry Clin Neurosci 2014;26:323-328
82. Tsai CS, Wu CL, Chou SY, et al: Prevention of poststroke depression with milnacipran in patients with acute ischemic stroke: a double-blind randomized placebo-controlled trial. International clinical psychopharmacology. Int Clin Psychopharmacol 2011;26:263-267
83. Reding MJ, Orto LA, Winter SW, et al: Antidepressant therapy after stroke: a double-blind trial. Arch Neurol 1986;43:763-765
84. Grade C, Redford B, Chrostowski J, et al: Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Arch Phys Med Rehabil 1998;79:1047-1050
85. Robinson RG, Schultz SK, Castillo C, et al: Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry 2000;157:351-359
86. Wiart L, Petit H, Joseph PA, et al: Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke 2000;31:1829-1832
87. Fruehwald S, Gatterbauer E, Rehak P, et al: Early fluoxetine treatment of post-stroke depression: a three-month double-blind placebocontrolled study with an open-label long-term follow up. J Neurol 2003;250:347-351
88. Rampello L, Alvano A, Chiechio S, et al: An evaluation of efficacy and safety of reboxetine in elderly patients affected by "retarded" poststroke depression: a random, placebo-controlled study. Arch Gerontol Geriatr 2005;40:275-285
89. Choi-Kwon S, Han SW, Kwon SU, et al: Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a double-blind, placebo-controlled study. Stroke 2006;37:156-161
90. Rasmussen A, Lunde M, Poulsen DL, et al: A double-blind, placebocontrolled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 2003;44:216-221
91. Almeida OP, Waterreus A, Hankey GJ: Preventing depression after stroke: results from a randomized placebo-controlled trial. J Clin Psychiatry 2006;67:1104-1109